Numstocker / Shutterstock.com

5 June 2025NewsAmericasSarah Speight

Fed Circ upholds Moderna’s COVID-19 vaccine win against Alnylam

Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

1 May 2025 Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity.

Moderna wins reprieve in COVID-19 vaccine dispute

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

Alnylam says Moderna used patented tech to make vaccine

22 March 2022 Alnylam Pharmaceuticals has accused Moderna of using its nanoparticle technology to develop its COVID-19 vaccine.

More on this story

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

1 May 2025 Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity.

Moderna wins reprieve in COVID-19 vaccine dispute

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

Alnylam says Moderna used patented tech to make vaccine

22 March 2022 Alnylam Pharmaceuticals has accused Moderna of using its nanoparticle technology to develop its COVID-19 vaccine.

More on this story

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

1 May 2025 Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity.

Moderna wins reprieve in COVID-19 vaccine dispute

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

Alnylam says Moderna used patented tech to make vaccine

22 March 2022 Alnylam Pharmaceuticals has accused Moderna of using its nanoparticle technology to develop its COVID-19 vaccine.

More features

‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal

Wilson Sonsini adds veteran USPTO examiner as senior patent counsel

Make your voice heard: Call for input on AI, the UPC, and patent trends

J&J unit could owe biotech $125m over AI-based surgical ‘night vision’ tech

FisherBroyles appoints biotech-focused partner in DC

Crowell & Moring and Faber Daeufer launch life sciences practice

Ukraine law change means rightsholders need to prepare

Honigman lands two leading litigators in Chicago office